Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...
Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology ...
Multiple Sclerosis/therapy,
Multiple Sclerosis/diagnosis,
Ataxia/therapy,
Selective Serotonin Reuptake Inhibitors/therapeutic use,
Fatigue/therapy,
Multiple Sclerosis/rehabilitation,
Fatigue/drug therapy,
Mobility Limitation,
Muscle Spasticity/drug therapy,
Dystonia/drug therapy,
Tremor/drug therapy
The update of the treatment manual "Management of generalized anxiety disorder and panic disorder (with or without agoraphobia) in family medicine" was initiated because more than five years had passed since the publication of the original manual in 2014. The procedure for updating treatment manuals is w...
Generar recomendaciones basadas en la mejor evidencia disponible acerca de la entrega de respecto a la pesquisa, diagnóstico y tratamiento de adolescentes con depresión.
Adolescentes sospecha o diagnóstico de depresión, que reciben atención en el nivel primario, secundario y terciario de salud en el...
Objetivos: El objetivo principal de esta Guía es recoger recomendaciones concretas basadas en los resultados de la literatura científica para tratar a pacientes con un trastorno mental grave y un consumo de sustancias atendidos en centros de tratamiento hospitalarios y ambulatorios. Incluye: 1) Recomen...
Mental Disorders/drug therapy,
Substance-Related Disorders/drug therapy,
Psychoanalytic Therapy,
Antidepressive Agents/therapeutic use,
Antipsychotic Agents/therapeutic use,
Clozapine/therapeutic use,
Dopamine Agonists/therapeutic use,
Naltrexone/therapeutic use,
Bupropion/therapeutic use,
Varenicline/therapeutic use,
Selective Serotonin Reuptake Inhibitors/therapeutic use,
Desipramine/therapeutic use,
Disulfiram/therapeutic use,
Buspirone/therapeutic use
This guideline covers recognising, assessing and treating social anxiety disorder (also known as ‘social phobia’) in children and young people (from school age to 17 years) and adults (aged 18 years and older). It aims to improve symptoms, educational, occupational and social functioning, and quality...
This guideline covers identifying and managing depression in adults aged 18 years and older, in primary and secondary care. It aims to improve care for people with depression by promoting improved recognition and treatment....
